Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(Q2)Mar 31, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | |
---|---|---|---|
Assets | |||
Current assets | |||
Cash, cash equivalents and short term investments | --86.18M | -12.18%156.35M | --178.03M |
-Cash and cash equivalents | --86.18M | -12.18%156.35M | --178.03M |
-Including:Cash | --86.18M | -12.18%156.35M | --178.03M |
Receivables | --94.15M | 69.39%77.83M | --45.95M |
-Accounts receivable | --94.15M | 69.39%77.83M | --45.95M |
Prepaid assets | ---- | 6.73%12.9M | --12.09M |
Other current assets | ---193K | -36.72%-13.4M | ---9.8M |
Total current assets | --180.14M | 3.28%233.68M | --226.27M |
Non current assets | |||
Net PPE | --13.14M | 17,872.97%6.65M | --37K |
-Gross PP&E | ---- | 631.53%7.7M | --1.05M |
-Accumulated depreciation | ---- | -3.74%-1.05M | ---1.02M |
Prepaid assets-non current | --24.69M | --25.1M | --0 |
Goodwill and other intangible assets | --39.03M | ---- | ---- |
-Other intangible assets | --39.03M | ---- | ---- |
Other non current assets | --1K | ---- | ---- |
Total non current assets | --76.87M | 85,718.92%31.75M | --37K |
Total assets | --257.01M | 17.29%265.44M | --226.3M |
Liabilities | |||
Current liabilities | |||
Financial liabilities | --450.78M | 71.91%452.34M | --263.12M |
-Current debt and capital lease obligation | --450.78M | 71.91%452.34M | --263.12M |
-Including:Current debt | --450.78M | 71.91%452.34M | --263.12M |
Payables | --42.2M | 3.83%34.32M | --33.06M |
-accounts payable | --42.2M | 3.83%34.32M | --33.06M |
Accrued and deferred income | --7.73M | -25.68%23.94M | --32.21M |
Other current liabilities | --24.09M | 450.43%7.74M | --1.41M |
Current liabilities | --524.79M | 57.17%518.34M | --329.79M |
Non current liabilities | |||
Non current financial liabilities | ---- | --0 | --2.08M |
-Long term debt and capital lease obligation | ---- | --0 | --2.08M |
-Including:Long term debt | ---- | --0 | --2.08M |
Other non current liabilities | ---- | ---- | ---1K |
Total non current liabilities | --1K | --0 | --2.08M |
Total liabilities | --524.79M | 56.19%518.34M | --331.87M |
Shareholders'equity | |||
Share capital | --8M | 0.00%8M | --8M |
-common stock | --8M | 0.00%8M | --8M |
Additional paid-in capital | --7.5M | ---- | ---- |
Retained earnings | ---283.37M | -121.76%-268.48M | ---121.07M |
Other reserves | ---- | 0.00%7.5M | --7.5M |
Other equity interest | --83K | --83K | ---- |
Total stockholders'equity | ---267.78M | -139.56%-252.9M | ---105.57M |
Total equity | ---267.78M | -139.56%-252.9M | ---105.57M |
Currency Unit | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |